News and stories
New imaging agent could improve early detection of inflammatory disease
Researchers from the Institute of Biomedical Engineering at the University of Toronto have developed a novel MRI contrast agent that may enhance the early detection of inflammatory diseases by targeting nitric oxide (NO), a key molecule involved in the body’s immune response.
Upcoming events
Oct
21
5:10 pm - 5:25 pm
Oct
21
5:25 pm - 5:40 pm
Oct
21
5:40 pm - 5:55 pm
Oct
21
5:55 pm - 6:10 pm